B3GNT8 ELISA kits are immunoassay tools for the measurement of the protein UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8, which is encoded by the B3GNT8 gene in humans. Functionally, this protein is a reported Beta-1,3-N-acetylglucosaminyltransferase that plays a role in the elongation of specific branch structures of multiantennary N-glycans. The canonical protein structure is reported to have an amino acid length of 397 residues, a mass of 43.4 kDa, and is a member of the Glycosyltransferase 31 protein family. It is known to be localized in the golgi and is reported to be highly expressed in small intestine, pancreas, spleen, bone marrow, lung, throat, and ileum, and weakly in fetal brain, cerebellum, heart, liver, tongue, breast, uteri, and testis. The protein has been noted to be post-translationally glycosylated. Other alias names for this target include UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 7, beta galactosyltransferase BGALT15, beta-1,3-Gn-T8, beta-1,3-N-acetylglucosaminyltransferase 8, and BGnT-8.
The detection range for different B3GNT8 ELISA kits can vary, with some assays measuring target concentrations as low as 0.156 ng/mL and as high as 10 ng/mL. Click on the products below for more detailed ELISA kit information, such as target reactivity and assay sensitivity.